From a vaccine for respiratory syncytial virus (RSV) to an infusion that slowed down Alzheimer’s for some people with the disease, here are three momentous advances from 2022.
An RSV vaccine showed promise for the first time in 50-years
Two vaccines are poised to be approved for RSV by the end of 2023, according to their makers, after almost 50-years without any meaningful progress.
Comments are closed.